ANXA2 and ovarian carcinoma: Through mass spectrometry analysis, co-immunoprecipitation, and immunofluorescence, we confirmed the interaction between these two proteins in ovarian cancer cells, and found that the combination of ANXA2 and HE4 activated the MAPK and FOCAL signaling pathways to promote the invasion and migration of ovarian cancer cells [24].